Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Victrex PLC Director's Dealing 2020

Dec 11, 2020

5290_dirs_2020-12-11_435b152a-6d06-48c5-be67-a4bee746c504.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 4363I

Victrex PLC

11 December 2020

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Martin Court
2 Reason for the notification
a) Position/status Executive Director (PDMR)
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Victrex plc
b) LEI 213800UYNPHAUNHPXL67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1p each
Identification code GB0009292243
b) Nature of the transaction Exercise of 2,402 nil cost options granted 5 December 2017 under the Victrex plc 2017 Deferred Bonus Plan, which comprised of 174 shares being made up of a net hypothetical dividend amount. 

Dr Court sold sufficient shares 1,051 arising from the exercise to cover costs, and retained the balnce as shares.
c) Price(s) and volume(s)
Price(s) Volume(s) sold Volume retained
£21.1881 1,051 1,351
d) Aggregated information
- Aggregated volume exercised

- No of shares retained
2,402

1,351
- Price £21.1881
e) Date of the transaction 2020-12-10
f) Place of the transaction Thornton, Cleveleys, Lancaire

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDZMMZDMVGGZM